Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eliem Therapeutics Inc (NQ: ELYM )

7.030 -0.040 (-0.57%)
Streaming Delayed Price Updated: 11:13 AM EDT, Jul 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Eliem Therapeutics Inc

Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
From Eliem Therapeutics, Inc.
Via GlobeNewswire
ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Eliem Therapeutics Provides Update on Pipeline Progress
From Eliem Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.